SEC FORM 4
—
Cytek Biosciences, Inc. (CTKB)
Acquisition (code M) of 14,220 shares; price not stated (see filing).
Reporting Person Yan Ming · Officer Title CHIEF TECHNOLOGY OFFICER · Transaction Code M
Traded Aug 18, 2026 · Disclosed Aug 20, 2026
Source: SEC Form 4 · 0001874041-26-000009 · filed 2026-08-20 · View filing →